Focuses on defining the complex interactions between multiple vulnerability genes and environmental adversity, resulting in mood disorders. Vulnerability genes result in functional and structural frailty of the circuits involved in regulation of mood and stress response. Repeated distress disrupts the ability of these brain circuits to maintain homeostasis and organize adaptive responses - producing disease symptoms.

Upon the completion of this activity, participants will be able to:

1. Describe the structural and functional changes that occur during the progression of stress and mood disorders.
2. Optimize pain management by understanding the relationship between chronic pain and mood disorders

Although we have grown accustomed to viewing depression as an illness of the mind, recent scientific understandings suggest that bodily processes-and especially inflammation-contribute significantly to the development and maintenance of mood disorders. An "inflammatory" view of depression also suggests that depression is not a discreet illness, but is rather a probabilistic set of symptoms that emerge from pathways that evolved to maintain adaptive homeostasis in the face of danger from predators and pathogens. This presentation explores how this new Mind-Body view unifies many currently unexplained areas in the pathophysiology and phenomenology of mood disorders in ways that have clear treatment implications. Vaccines for depression anyone?

Upon the completion of this activity, participants will be able to:

1. Identify the relationship of inflammation, stress and mood disorders (ie, the neurobiological correlates).
2. Describe the structural and functional changes that occur during the progression of stress and mood disorders.

Describes the somato-psychic aspects of mood disorders. Products of perturbed autonomic, neuro-endocrine and neuro-immune regulation reach the brain. Here these compounds, generated in the periphery, impact on delicate communication between the various types of glia cells and neurons. Ensuing disturbance in synaptic function and intra-cellular signaling further compromises the ability of critical brain circuits to re-establish homeostasis-thus augmenting the disease process.

Upon the completion of this activity, participants will be able to:

1. Describe the structural and functional changes that occur during the progression of stress and mood disorders.
2. Recognize the importance of full symptomatic and functional recovery (ie remission) as an optimal treatment outcome of mood disorders.

Join the entire faculty of Treating the Whole Patient for an Extended Question and Answer session at the end of Day 1.

Accurate assessment of suicidality remains one of our most difficult tasks. You will learn the latest research on risk factors for suicide. You will increase your skill in eliciting relevant information. Dangers of no-suicide contracts will be reviewed along with other pitfalls of potential liability for failing to prevent suicide.

Upon the completion of this activity, participants will be able to:

1. Improve assessment skills for suicide risk;
2. Recognize liability for completed suicide;
3. Learn liability prevention strategies

In this companion course, Dr. Schuyler will present the various formats in which he has worked with cancer patients. He will focus on what he has learned: about cancer, relating to oncologists, deference, inferences, and the most common emotional disorder seen in this group. He will contrast his work in a university setting with that of a private oncology practice. Then, he will discuss stages of cancer and its treatment that are relevant to adjustment, typical reactions seen in cancer patients, and the difficult time when treatment ends. Issues of reimbursement, will be explored along with the contrasts in both University Setting and Private Practice.

1. Develop sensitivity to the needs, habits, and styles of oncologists in approaching psychological work with cancer patients;
2. Become familiar with the challenges to the individual cancer patient provided by the different stages of the illness; and
3. Develop an approach to the patient with cancer aimed at facilitating a healthy adaptation to the illness.

Tremendous progress has been made in developing animal models for addictions, new treatments based on these models and testing these in patients with drug and alcohol dependence. We will review the most current research and state-of-the-art treatment for tobacco, alcohol, and other drugs of abuse and provide a framework for understanding current progress, limitations, and hope for the future.

By participating in this activity, attendees will be able to:

1. List major illnesses associated with obesity;
2. Discuss the epidemiology of obesity and overweight; and
3. Assess current theories, current treatment approaches-including minimally invasive surgery-and experimental approaches that have resulted from tests concluding that highly palatable, erotic and exotic foods act in the brain as a drug of abuse.

Do the media merely "reflect" the real world - as Hollywood and network executives would have us believe - or do they cause real-life problems as well? Do the media contribute to early sexual intercourse? Could the media increase teens' use of contraception? This talk will try to illuminate what we know about the impact of the media on adolescents, what we don't know, and what we need to do to find out. Several suggestions for parents and for schools will be presented.

By participating in this activity, attendees will be able to:

1. Describe the nature of current television programming for adolescents;
2. Discuss the impact of television programming on children and teens and how such effects were determined by research; and
3. Identify how the adverse effects of TV and other media can be mediated by parents and by school media literacy programs.

For far too long clinicians have viewed depression and other neuropsychiatric disorders as "brain illnesses", versus various systemic diseases like hypertension and diabetes as "body illnesses". Based on emerging evidence this dichotomy is flawed and the new concepts exemplified in the Mind/Body science have challenged us to "reconnect" brain to body. This presentation seeks to review this critical relationship and elucidate for the clinician the various systemic medical consequences associated with a "dysregulated" mind and body.

Upon the completion of this activity, participants will be able to:

1. Describe the structural and functional changes that occur during the progression of stress and mood disorders.
2. Identify the relationship of inflammation, stress and mood disorders (ie, the neurobiological correlates).

The session will provide participants with recent clinical trial data on therapeutics for the treatment of ADHD. In addition the symposium will focus on recognizing, reducing, and addressing stimulant abuse and diversion.

This activity is supported by an educational grant from Eli Lilly and Company.

This activity is sponsored by CME LLC. Veritas Institute for Medical Education, Inc. is the content provider.

You will learn predictors of violence and interview techniques in the assessment of dangerousness. Violence will be discussed in persons with various symptoms of psychosis. You will learn how to appraise "perceived intentionality," and other aspects of paranoia.

Upon the completion of this activity, participants will be able to:

1. Identify predictors of violence.
2. Learn interview techniques in the assessment of dangerousness.
3. Develop violence reduction plans.

While Substance Use Disorders have been primarily thought of as those involving chemical substances like tobacco or alcohol , more recently process addictions have been studied . Once the DSM 3 diagnostic scheme was changed to accommodate cocaine and minimize withdrawal or abstinence, gambling and sexual compulsivity have been studied and suggested to be addictions. These process addictions have much neurobiology and phenomenology in common with chemical addictions and this construct may be especially helpful in understanding the obesity epidemic and logical public health and treatment approaches.

Upon the completion of this activity, participants will be able to:

1. Review current epidemiological data on substance abuse disorders.
2. Review examples of common co-occurring disorders such as tobacco smoking and alcohol and depression.
3. List and Discuss diagnostic and treatment issues for co-occurring alcohol and tobacco-related illnesses.

Dr. Schuyler has been a pioneer in the application of cognitive therapy. A Founding Fellow of the Academy of Cognitive Therapy, his latest focus is aimed at aiding the adjustment of the patient diagnosed with cancer. In this course, he will discuss the thinking underlying the use of cognitive therapy to help the patient with severe medical illness. He will then highlight useful cognitive techniques to aid adjustment to cancer. In time set aside for questions, Dr. Schuyler will encourage clinicians to work with this needy population.

Upon completing this activity, participants will be able to:

1. To apply Cognitive Therapy's usefulness in aiding adjustment to severe illness.
2. Discuss the differences between what cognitive therapy and what it is not.
3. Utilize cognitive therapy techniques for work with cancer patients.

Psychiatrists face a daunting task every day- diagnosing patients using an imperfect diagnostic manual, limited data and external pressures. Problems with diagnosis can impact treatment outcomes and clinician liability. Tools used in forensic psychiatry may improve diagnostic validity and reliability in clinical psychiatric practice. This session will review some of the problems we face in psychiatric diagnosis as well as a practical comparison of how clinical and legal decision makers use "evidence," explore uncertainty and avoid pitfalls. The participants will identify pitfalls and potential remedies to a sample case.

Upon the completion of this activity, participants will be able to:

1. Illustrate reliability of several DSM-IV diagnoses;
2. Compare clinical and legal approaches to "the evidence" and decision making; and
3. Identify tools that can enhance clinical diagnosis and management.

Upon completion of this activity, participants will be able to:

1. Understand how the menstrual cycle and perimenopause can affect psychiatric symptoms;
2. Understand how to modify psychopharmacologic treatment for premenstrual and perimenopausal symptoms;
3. Consider other clinical interventions for premenstrual and perimenopausal psychiatric symptoms

Dementia, mania, psychosis and neuropathy are familiar manifestations of late-stage HIV/AIDS disease. Some antiretrovirals used to treat HIV are also associated with neuropsychiatric side effects.

By participating in this activity, attendees will be able to:

1. Identify neurologic and psychiatric comorbidities commonly seen in the HIV population and discuss their association with HIV infection and treatment;
2. Discuss common neuropsychiatric complications associated with HIV disease and HIV therapies and outline the strategies for managing these complications; and
3. Recognize the impact of neuropsychiatric disorders with immunologic and virologic measures of HIV disease progression.

Bipolar disorder presents significant challanges to patients and their mental health and medical treatment team. Accurate diagnosis is essential to prevent making the situation worse. Treatment is complicated with ever changing treatment needs and goals.

By participating in this session, learners will be able to:

1. More accurately diagnose and successfully manage BD;
2. Utilize current advances in the use of combination versus monotherapy to optimize relapse prevention in the acute and long-term management of BD;
3. Identify strategies to optimize individual patient management of BD including related psychiatric and medical comorbidities and improve adherance rates;
4. Understand the role of antidepressants in the treatment of BD.

With the rise in malpractice suits, it's more important than ever for mental health professionals to find out how to reduce their risk.

By participating this activity, attendees will be able to:

1. Analyze basic concepts in the law of negligence;
2. Discover common causes of action against mental health professionals; and
3. Prepare to reduce these risks in their practices.

The session will provide participants with strategies for the management of adolescents with depression.

This activity is supported by an educational grant from Forest Laboratories, Inc.

This activity is jointly sponsored by The Albert Einstein College of Medicine with Montefiore Medical Center and CME LLC.  The Institute for Continuing Healthcare Education is the content provider.

Emerging evidence compels us to take a fresh look at the treatment of depression. Quite forcefully, data directs us to view depression as a mind-body disorder. As a result, today's clinicians need to expand their treatment paradigms to be inclusive of  mind-body disruptions (not one or the other, but both). This section of the comprehensive mind-body presentation examines treatment data in detail, and offers clinicians cutting edge tools and paradigms to achieve optimum outcomes as they treat patients afflicted with depression.

Upon the completion of this activity, participants will be able to:

1. Recognize the importance of full symptomatic and functional recovery.
2. Identify the relationship of inflammation, stress and mood disorders (ie, the neurobiological correlates).
3. Discuss the significance of the biological, psychosocial, and nonpharmacological treatment options in the treatment of depression.

The session will provide participants with practical strategies for the diagnosis, treatment, and long term management of patients with schizophrenia.

12:15 - 12:45 p.m. Lunch
12:45- 2:15 p.m. Symposium

This activity is supported by an educational grant from Eli Lilly and Company.
This activity is sponsored by CME LLC. CME Outfitters is the content provider.

Emerging evidence compels us to take a fresh look at the treatment of depression. Quite forcefully, data directs us to view depression as a mind-body disorder. As a result, today's clinicians need to expand their treatment paradigms to be inclusive of  mind-body disruptions (not one or the other, but both). This section of the comprehensive mind-body presentation examines treatment data in detail, and offers clinicians cutting edge tools and paradigms to achieve optimum outcomes as they treat patients afflicted with depression.

Upon the completion of this activity, participants will be able to:

1. Recognize the importance of full symptomatic and functional recovery.
2. Identify the relationship of inflammation, stress and mood disorders (ie, the neurobiological correlates).
3. Discuss the significance of the biological, psychosocial, and nonpharmacological treatment options in the treatment of depression.

Primary care providers have less time to deal with an increasing number of health issues. When a patient presents with multiple complaints and persistent pain, primary care will attribute all the symptoms to the underlying psychologic stressors. Persistent pain worsens psychological adaptation and depression and anxiety make pain worse. Having a supportive relationship with primary care providers leads to better patient care and improved outcomes.

Upon the completion of this activity, participants will be able to:

1. Describe what primary care is looking for in referring patients with persistent pain;
2. Prepare the referring provider to care for future, similar patients; and 3) Separate the pain complaints from the psychologic issues.

Aggressive behavior is the one of the most common referral problems in child and adolescent psychiatry.

By participating in this activity, attendees will be able to:

1. List the psychiatric conditions that are associated with aggression;
2. Discuss the biological, social and psychological factors underlying the aggressive behavior; and
3. Identify the preventive interventions that will address building the therapeutic alliance with the parents and the adolescent, addressing the cultural issues, treating the comorbid psychiatric conditions etc.

Behavioral Health is constantly changing, and a large percentage of behavioral health organizations have seen a steady increase in denied claims. These health care claims which are rejected or denied lead to millions of dollars of lost revenue each year for health care organizations. Begin turning around the denial rate of your organization by attending Understanding Managed Care: Reducing Denials. This presentation is a must attend event for anyone working in the health care field. Impactful change is possible, and there are proven key steps to reducing insurance denials. Find out more about this topic and what you can do to optimize profitability, decrease costly denials, and improve your daily work load.

After completing this educational activity, participants should be able to:

1. Have a detailed understanding of the authorization and denial process that Managed Care Organizations use;
2. Identify the rules that Managed Care Organization should be following and the appeal rights; and
3. List and be able to utilize the CORE Principles to reduce denials".

Join the entire faculty of Treating the Whole Patient for an Extended Question and Answer session at the end of Day 2.

Upon the completion of this activity, participants will be able to:

1. Understand how pregnancy and the postpartum period affect the course and expression of mood disorders;
2. Understand the risks of untreated symptoms of mood disorders during pregnancy and postpartum;
3. Understand the risks of antidepressant and mood-stabilizing medications during pregnancy and postpartum, and prescribing practices that can minimize risks

Cognitive outcome in adolescents is shaped by etiological factors and the underlying neuropathology in a range of developmental and acquired brain disorders.

Upon the completion of this activity, participants will be able to:

1. Discuss the neuropsychological disorders in adolescents and their functional implications;
2. Recognize the brain-behavior relationship from the prenatal period through late adolescence within the context of typical and atypical development; and
3. Identify collaborative and consultative approaches within the context of the neuropsychological evaluation.

Fibromyalgia syndrome affects 3-5% of the population and is the second most common presenting complaint in rheumatology. Primary care providers have difficulty caring for patients with fibromyalgia due to a wide array of pain and non-pain complaints including headache, abdominal pain, irritable bladder, jaw pain, insomnia, numbness and difficulty concentrating as well as others. Many of the presenting complaints may be psychologic in nature, but the underlying disease is distinct from the presenting depressive and anxiety symptoms. Sorting the myriad complaints and providing structure can be lifesaving for patients with fibromyalgia and is best treated by those skilled in psychology.

At the end of this activity, attendees will be able to:

1. Describe the current science about the pathophysiology of fibromyalgia syndrome;
2. Help the referring provider to manage the pain and psychosocial issues; and
3. Treat patients with pharmacologic and nonpharmacologic options.

What if, for the same hour of work, you could increase your reimbursement by 20%? Or 50%? Or even 100%? It would be like that money you found in the seat cushion, wouldn't it? The reality of most practices is that with correct coding and documentation, revenue increases of this magnitude can be possible. Best of all, it can be achieved without significant new effort by you - it's just a matter of understanding the proper codes and documentation you need to support your charges.

In this session, we introduce you to the basics of Correct Coding including ICD-9 / DSM IV diagnostic code basics, Correct Procedural (CPT) coding for Behavioral Health Professionals. We will focus on basic coding techniques and practices for psychiatric and psychotherapy encounter including hints and tips to reduce denials and improve overall reimbursement.

Upon the completion of this activity, participants will be able to:

1. Understand what ICD-9, DSM IV, and CPT codes are, what they mean, and when to use them
2. Unerstand how to use Common CPT codes for Behavioral Health Management
3. Increase overall reimbursement through hints and tips they learned for improving coding

BasicNeeds (BN) is arguably the leading mental health organization in the developing world, working in 8 developing countries with new partnerships underway. Founded in the UK in 2000, BN has developed a Model for Mental Health and Development that provides a framework for and guides its work. This course describes the Model for Mental Health in the Developing world in some length and will draw parallels to US public mental health policy. Despite the enormous differences between the US and developing nations, this model is extremely relevant to US public mental health programs working with the seriously mentally ill and in resource poor locations. The course will end with a broader discussion of the future for BasicNeeds and the common challenges of sustainability faced by all mental health programs in resource poor areas.

Upon the completion of this activity, participants will be able to: . Provide a detailed description of the elements of BasicNeeds' mental health and development model . Demonstrate how these elements work in developing countries through case examples and discussion . Describe how BasicNeeds has implemented the model in different countries and the outcomes we have achieved . Describe new strategies for mental health program sustainability

Psychosocial support is an important aspect of HIV/AIDS care which enables people to function during overwhelmingly adverse circumstances and problems caused by HIV and AIDS.

By participating in this activity, attendees will be able to:

Dr. Stein examines the relationship of the two "signature injuries" experienced by Operation Enduring Freedom (OEF) and Operation Iraqi Freedom (OIF) troops, posttraumatic stress disorder (PTSD) and mild traumatic brain injury (mTBI). Studies show that a minority of individuals develop persistent emotional, somatic, and/or cognitive sequelae of traumatic exposure. Remarkably, the mechanism (emotional vs. biomechanical) or locus (head vs. other physical) of injury is a weak determinant of whether an individual develops PTSD, persistent postconcussive symptoms (PCS), or both. The frequent convergence of PTSD and PCS symptoms in military personnel is discussed, with an emphasis on studies that evaluate risk factors and outcomes. A general approach to management is discussed, as are new directions in diagnostic and therapeutic research.

Upon the completion of this activity, participants will be able to:

1. List criteria for the diagnosis of mild traumatic brain injury (mTBI);
2. Review the extent of symptom overlap between mTBI and posttraumatic stress disorder (PTSD); and
3. Describe new directions in the diagnosis and management of comorbid mTBI and PTSD

The session will provide participants with insight into insomnia management through discussions of assessment, treatment implications, and patient education strategies.

7:00-7:30 a.m. Breakfast
7:30-9:00 a.m. Symposium

This activity is supported by an educational grant from sanofi-aventis U.S.
This activity is sponsored by CME LLC. MediCom Worldwide, Inc. is the content provider.

Although close to 80% of all individuals with dementia suffer from Alzheimer's disease, there are still many other critically important subtypes of dementia that must be recognized by the clinician. This symposium will provide a broad definition of dementia and then focus on some of the most important medically-induced subtypes and how to recognize them. Subtypes to be covered include normal pressure hydrocephalus, dementias due to human prion diseases and HIV infection, traumatic brain injury, and dementias that result from toxic exposures such as to alcohol or heavy metals.

After Participating in this activity participants will be able to:

1. Discuss the entire spectrum of non-Alzheimer dementia subtypes
2. List what diagnostic signs point to a potential medically-induced form of dementia.
3. Discuss diagnosis and treatment of the following dementia subtypes: A) Normal pressure hydrocephalus.
4. Human prion diseases.
5. HIV associated dementia.
6. Dementia due to traumatic brain injury(e.g., dementia pugilistica).
7. Dementia due to ETOH and other toxic exposures. F) Dementia due to neurodegenerative diseases (e.g., multiple sclerosis).

Dreams have been an important aspect of man's search for meaning for over 4000 years. In this seminar, attendees will be exposed to a modern approach to dream analysis, one that integrates the insights and approaches of such luminaries as Freud, Jung, Perls and Hall. Research will be provided to validate the usefulness of using dreams in therapy and the applicability of the "continuity model". Sleep studies will also be used to better understand the stages of sleep and patterns of REM and NREM sleep. Case studies will be presented as well to illustrate a modern approach to helping clients remember and find meaning in their dreams.

Upon the completion of this activity, participants will be able to:

1. Identify benefits of dream work;
2. Review historical models;
3. Present a modern model;
4. Debunk common myths about dreams; and
5. Review relevant research.CA112

Many experts say that the key to treating patients with agitation, aggression and dangerousness is to understand the factors that lead to this behavior and the treatments that are currently available.

By participating in this activity, attendees will be able to:

1. Discuss the etiology of agitative and aggressive feeling and dangerous behavior, and explore how various forms of psychiatric comorbidity increase the likelihood of such behavior;
2. Recognize the effective ways to conduct accurate risk assessments; and
3. Identify various integrated treatments, including cognitive behavioral and other skill-based interventions, to address such behavior.

Upon the completion of this activity, participants will be able to:

1. Avoid major pitfalls of both tangible & intangible marketing;
2. . Explain the ramifications of patient services and integrate this knowledge into better patient care; and
3. Develop a marketing budget and an effective 12-Month Marketing Plan, individualized for their practice.

Increasing numbers of teens and young adults cut, scratch or burn themselves to feel better. Treatment providers (and family members) can inadvertently escalate self-injury unless shown effective ways to support these individuals. Join us in this high-energy, practical session replete with video clips and case examples.

By participating in this activity, attendees will be able to:

1. Explain why individuals self-injure and how "cutting" and "burning" differ from suicide;
2. Learn to screen for self-injury; and
3. Learn practical and effective "strategies" to use with individuals who engage in this harmful behavior.

Psychiatric masquerades are medical and/or neurological conditions which present primarily with psychiatric or behavioral symptoms. The conditions included in this category range from neurological disorders (e.g. seizure disorders and MS), to infectious diseases (e.g. syphilis, herpes and HIV), to connective tissue disorders (e.g. vasculitis and SLE), to malignancies (e.g., paraneoplastic syndromes and pancreatic cancer), to metabolic disorders (e.g. Wilson's disease and prophyria), to various toxins and substances our patients may be exposed to. In this lecture, we will discuss the presentation and symptoms of the most common masquerades, focusing on pearls for timely diagnosis, and discuss potential management and treatment strategies.

By participating in this activity, attendees will be able to:

1. Recognize the most common infectious disorders presenting with psychiatric symptoms;
2. Explain the incidence, epidemiology and clinical features of the most common neuropsychiatric disorders masquerading as psychiatric illness;
3. Recommend the research-based, effective treatment options for these conditions.

Treating patients who suffer from Anorexia and/or Bulimia can cause psychiatrists and psychotherapists tremendous frustration or great satisfaction. Successful treatment of Eating Disorders requires a complete understanding of the multiple etiologies involved, the psychotherapies required and the sophisticated use of psychotropic medications. We will focus in this session on the keys optimizing clinical outcomes and achieving remission based upon the biopsychosocial etiology of these disorders. We will identify the factors that result in failure and frustration, as well as the keys to successfully reach appropriate treatment goals.

By participating in this activity, learners will be able to:

1. Understand the multimodal treatment necessary for the successful treatment of these biopsychosocial disorders.
2. Enhance their ability to successfully utilize cognitive/behavioral psychotherapeutic techniques within a dynamic understanding of Anorexia and Bulimia.
3. Update their ability to successfully utilize psychopharmacologic agents to treat Eating Disorders.

Forensic psychiatry is an emerging area of specialization in psychiatry and it is important for general psychiatrists to familiarize with this area to help in their interface with the legal system.

By participating in this activity, attendees will be able to:

1. Discuss the commonly encountered psychiatric problems in correctional centers;
2. To become familiar with the prevalence of mental illness in Correctional facilities and to understand the complexities of assessment and treatment of the mentally ill in this setting; and
3. Identify the legal challenges practitioners face.

The psychiatric consultant is often asked to help manage the MOST CHALLENGING demented patients. Often , these patients have Lewy Body Dementia or FrontoTemporal Dementia. Learn how to recognize and treat these conditions with actual patient videos which demonstrate key findings.

Upon the completion of this activity, participants will be able to:

1. Discuss the diagnosis and clinical presentation of Lewy Body Dementia and Frontotemporal Dementia;
2. Describe the pathophysiological mechanisms associated with dementia;
3. Review the nonpharmacological and pharmacological treatments for various dementia

Spirituality and religion are important aspects of life. While research indicates that clients want providers to ask about these areas of their lives, however, mental health providers are often ill-prepared to do so. This course will expose participants to several different mnemonic tools which are useful in interviewing clients about religion and spirituality. Special focus will be on the ChaMB mnemonic, an interviewing tool developed by the presenter for use with patients facing existential crises in their lives (i.e. death of a loved one; terminal illness; chronic illness etc.). Case examples will demonstrate the utility of this tool in both in-patient and out-patient settings.

Upon the completion of this activity, participants will be able to:

1. Provide mnemonic to help clinicians interview patients having experienced traumatic events;
2. Contrast with other tools to conduct spiritual interview; and
3. Use case material to illustrate efficacy.
4. Review relevant research findings

Do the media merely "reflect" the real world - as Hollywood and network executives would have us believe - or do they cause real-life problems as well? Teenagers spend an average of 6 hours a day with media: how much of an impact does that have on their attitudes and behavior? The answer lies partially in some voluminous and difficult media research and partially in the realm of common sense. This talk will try to illuminate what we know about the impact of the media on adolescents, what we don't know, and what we need to do to find out. The topics of violence, advertising, obesity, sex & sexuality, drugs, and new technologies will be explored, along with videotaped clips to illustrate the problems and some of the solutions. Several suggestions for parents and for schools will be presented.

Upon the completion of this activity, participants will be able to:

1. Illustrate the nature of current television programming for children and teenagers (topic areas = violence, commercialism, sex, drugs).
2. Discuss the impact of television programming on children and teenagers and how such effects were determined by research.
3. Analyze how the adverse effects of TV and other media can be mediated by parents and by school media literacy program.

Behavioral Health is constantly changing, and a large percentage of behavioral health organizations have seen a steady increase in denied claim and reduced revenue. These health care claims which are rejected or denied lead to millions of dollars of lost revenue each year for health care organizations. Begin turning around the reduced revenue of your organization by attending Understanding Managed Care: Increasing Profitability. This presentation is a must attend event for anyone working in the health care field. Impactful change is possible, and there are proven key steps to improving revenue. Find out more about this topic and what you can do to optimize profitability, decrease costly denials, gain a full working knowledge of coding, and learn what strategies pay when it comes to collections.

Upon the completion of this activity, participants will:

1. Have an understanding of the importance of data, tracking, and benchmarking and be able to begin to use these principles to improve outcomes in their practice.
2. Be able to utilize at least three strategies to immediately improve their practice's bottom line.
3. Understand the importance of the billing cycle and ways to improve the amount and rate at which revenue is collected.

Increasing numbers of teens and young adults cut, scratch or burn themselves to feel better. Treatment providers (and family members) can inadvertently escalate self-injury unless shown effective ways to support these individuals. Join us in this high-energy, practical session replete with video clips and case examples.

By participating in this activity, attendees will be able to:

1. Explain why individuals self-injure and how "cutting" and "burning" differ from suicide;
2. Learn to screen for self-injury; and
3. Learn practical and effective "strategies" to use with individuals who engage in this harmful behavior.

Psychiatric masquerades are medical and/or neurological conditions which present primarily with psychiatric or behavioral symptoms. The conditions included in this category range from neurological disorders (e.g. seizure disorders and MS), to infectious diseases (e.g. syphilis, herpes and HIV), to connective tissue disorders (e.g. vasculitis and SLE), to malignancies (e.g., paraneoplastic syndromes and pancreatic cancer), to metabolic disorders (e.g. Wilson's disease and prophyria), to various toxins and substances our patients may be exposed to. In this lecture, we will discuss the presentation and symptoms of the most common masquerades, focusing on pearls for timely diagnosis, and discuss potential management and treatment strategies.

By participating in this activity, attendees will be able to:

1. Recognize the most common infectious disorders presenting with psychiatric symptoms;
2. Explain the incidence, epidemiology and clinical features of the most common neuropsychiatric disorders masquerading as psychiatric illness;
3. Recommend the research-based, effective treatment options for these conditions.

While we attempt to make evidence-based decisions, the evidence in Psychiatry is incomplete and contradictory. Psychiatry is usually practiced behind closed doors in 1 to 1 confidential patient interactions. We want to learn how our psychiatric colleagues make difficult psychiatric decisions and treatment recommendations, but we have few opportunities to do so. Do they prescribe antidepressants for bipolar depression? or give benzodiazepines to patients with histories of substance abuse? How do they choose between augmentation options? Etc. When, Why and How do they make these and other complex treatment decisions? Join us in this stimulating interactive session as we utilize computerized response systems to explore these treatment questions and dilemmas. Learn, engage and participate with us. Bring your own cases, questions and treatment dilemmas.

By participating in this session, learners will be able to:

1. Learn how fellow psychiatric colleagues approach challenging treatment decisions in Mood and Anxiety Disorders.
2. Recognize the need for treatment decisions to be based on scientific evidence and clinical experience and acumen.
3. Enhance your ability to successfully treat Mood and Anxiety Disorders.

Health care reform has opened the door to integrating psychiatric mental health and behavioral interventions into medical settings. With a call for the Integrated Medical Home, prevention and patient wellness education will be rewarded as an innovation that will drive down medical costs. This opens the door for psychiatric mental health practitioners of all levels to apply the evidence based practices of the field to short term treatments in primary care settings. To capitalize on this evolution of our professions, we need to understand how to work collaboratively with medical offices, and the new NCQA standards for the patient centered medical home that focuses on early identification, patient education and modalities that can be effective in treatment of psychiatric mental health and behavioral issues in the primary care environment. By understanding the business issues involved with using commercial-based insurance, psychiatric nurses (RN,CNS, or NP), and other psychiatric mental health clinicians will have new opportunities to engage his or her full scope of practice that will directly impact patients' lives.

Participants should be able to:

1. Identify elements of collaboration in medical setting;
2. Understand what is needed to get credentialed and paid for collaborative services;
3. Define the role and training needs to participate in collaborative care;
4. Illuminate the issues involved in creating a model of collaborative care programs in your community; and
5. Understand the steps needed in developing community outreach and collaboration tools.

The fastest growing age group in the country is individuals of 85 years and above. As a result, it is becoming increasingly common for therapists to work with a significant number of older clients. This symposium will provide a context for such work along with many therapeutic tools. The aging process will be described with a focus on changes in cognition and personality that are relevant to late-life psychopathology. The symposium will then jump right into the therapeutic setting, discussing the role of the therapist, the impact of countertransference and stigma, and an approach to the diagnostic interview and psychotherapy that is both practical and age-specific.

Upon the completion of this activity participants will be able to:

1. Review the aging process and its relevance to cognition and personality throughout the life cycle.
2. Describe age-specific challenges encountered in therapy.
3. Discuss the role of countertransference and stigma when working with older client.
4. Apply Learn practical psychotherapeutic modalities in later life patients.

The session will provide participants with practical tools for the continuity of care for patients with schizophrenia.

This activity is supported by an educational grant from Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc. administered by Ortho-McNeil Janssen Scientific Affairs, LLC

This activity is jointly sponsored by the Indiana University School of Medicine and CME LLC. CME Outfitters is the content provider.

The session will provide participants strategies and reinforcement in dose titration, multimodal treatment, and long-term treatment adherence for patients with ADHD.

12:15 - 12:45 p.m. Lunch
12:45- 2:15 p.m. Symposium

This activity is supported by an educational grant from McNeil Pediatrics, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., administered by Ortho-McNeil Janssen Scientific Affairs, LLC

This activity is jointly sponsored by The Albert Einstein College of Medicine with Montefiore Medical Center and CME LLC. Veritas Institute for Medical Education Inc. is the content provider.

The session will provide participants with strategies for improving the management of comorbid depression as well as chronic pain and other physical symptoms.

12:15PM-12:45 p.m. Lunch
12:45-2:15 p.m. Symposium

This activity is supported by an educational grant from Eli Lilly and Company.

This activity is jointly sponsored by The Albert Einstein College of Medicine with Montefiore Medical Center and CME LLC. The Institute for Continuing Healthcare Education is the content provider.

Get up to date review of our current understanding of the biological basis of Depression. Information will emphasize factors involved with aging, brain localization, neurotransmitters, hormones, and treatments for the elderly depressed patient.

1. Discuss the clinical and psychosocial impact of depression and the significance of sustained remission in optimizing patient outcomes;
2. Describe evidence for the neuroanatomical correlates of depression and their relationship to vascular diseases; and
3. Utilize a neurobiological understanding of depression in identifying the most appropriate treatment options for depressed patients.

For the first time in a decade, youth suicide is on the rise.

By participating in this activity, attendees will be able to:

1. Identify two new trends in youth suicide and why they are so troublesome;
2. List both the subtle and obvious factors leading to suicide in children and teens-including the "Big 3"; and
3. Describe the four essential parts of suicide screening of youth.

Walking away from the closed door of our office, into medical offices, opens the door for new applications of psychiatric mental health and behavioral interventions that will drive down medical costs. Collaborating with primary care providers directly in medical offices requires new skills built on the understanding of the office, community and patient cultures. This discussion about the integrated mental health will focus on clinical issues, skill development, complementary and alternative mental health practices and how to work with health care reform to perpetuate a new clinical environment rich in opportunities for clinical research and outcome studies. This presentation will address behavioral interventions indicated for several medical conditions (diabetes, cardiac disease, infertility, pulmonary disease, and autoimmune diseases) as well as the collaborative process. While this presentation will highlight the role of psychiatric nurse in this exciting milieu, it could enhance the knowledge base of all practitioners interested in participating in a integrated medical home.

Participants should be able to:

1. Identify boundaries to the collaborative process and appropriate safeguards for patient information;
2. Define the process for comprehensive assessment and wellness planning;
3. Define the impact of mental illness on specific diseases discussed;
4. Identify collaborative involvement, role in referral and follow up;
5. Develop a tool specific to attendees' practices that will enhance the role, health care management, and communication between team members.

The evidence base for pharmacotherapy of PTSD has grown by leaps and bounds in the past 10 years. Early studies of amitriptyline and phenelzine showed some promise for treatment of PTSD. But sample sizes were small and larger-scale studies have not been conducted. Only one class of drugs, the selective serotonin reuptake inhibitor (SSRIs) has members of the class FDA-approved for PTSD. Numerous large, multi-center trials of SSRIs (and, more recently, several large trials with dual norepinephrine serotonin reuptake inhibitors [NSRIs]) conclusively demonstrate their short- and intermediate-term efficacy, but response rates are modest and the optimal duration of treatment is unclear. Furthermore, the efficacy of SSRIs in some populations (e.g., combat veterans with PTSD) has been questioned. As awareness of the prevalence and seriousness of PTSD has increased, so has the impetus to develop new and better treatments. Several other classes of medications, including anticonvulsants, atypical antipsychotics, and adrenergic agents (e.g., prazosin) have shown promise in relatively small studies for either monotherapy or adjunctive use. For some medications, large randomized controlled trials (RCTs) have been negative (e.g., the anticonvulsant tiagabine), whereas for others such trials are either ongoing (e.g., prazosin and risperidone) or have yet to be conducted (e.g., lamotrigine). A role for combined psychotherapy and pharmacotherapy of PTSD will be discussed.

Upon the completion of this activity, particpants will be able to:

1. List FDA approved treatments for posttraumatic stress disorder (PTSD).
2. Identify the different classes of psychotropic agents that may be useful in the treatment of PTSD.
3. Discuss the limitations of the available evidence base for PTSD pharmacotherapy and of the need for more studies and better therapeutics.

This introductory lecture will review the history of Hypnosis and its use in medical and psychiatric conditions. Common misconceptions about Hypnosis will be discussed as well as an introduction to hypnotic phenomena. Lastly, vignettes will be presented demonstrating the application of Hypnosis in several clinical conditions.

Upon the Completion of this activity, participants will be able to:

1. Discuss the common misconceptions about Hypnosis with patients and clients and to present the use of Hypnosis in such a way that will set the stage for a more successful outcome with this modality.
2. Use an understanding of the hypnotic phenomena and suggestibility tests to decide if Hypnosis may be a useful intervention for a given patient or client.
3. List the clinical uses of Hypnosis and to be able to apply this therapy to a wide range of medical, psychiatric, and psychotherapeutic settings.

Upon the completion of this activity, participants will be able to:

1. Recognize patients with environmental sensitivities by asking a few screening questions.
2. Help the patient determine what environmental factors are or have potentially affected their health. Focusing on mold at home or work as a common culprit.
3. Recognize adrenal insufficiency, dysautonomia, mitochondrial compromise and chemical sensitivity in your patients and obtaining proper referral for these conditions in your area.

Upon the completion of this activity participants will be able to:

1. Apply evidence-based medicine to the treatment of TIA and Stroke;
2. Learn different stroke subtypes, risk factors, and clinical syndromes;
3. Discuss new definition of TIA; and
4. Understand the role of intravenous vs. intra-arterial thrombolysis in acute stroke.

Both psychiatric and nonpsychiatric clinicians tend to underutilize screeners and rating instruments in their busy practices. This is an error worth rectifying expeditiously for the following reasons: use of screeners and rating instruments can actually improve outcomes, it can be very time efficient and many quality tools are available for no charge. This workshop will show videos of a few clinical scenarios and discuss what tools might have been appropriate to use. Copies of noncopyrighted screeners and rating instruments, appropriate for both psychiatric and nonpsychiatric settings, will be made available to participants. A toolkit filled of screeners and rating instruments will be brought to the workshop to show participants how they can create one for their own use.

By participating in this activity, attendees will be able to:

1. Recognize the many noncopyrighted tools available for clinician use covering a range of psychiatric disorders;
2. Define these tools that are very time efficient and improve diagnostic yield; and
3. Describe how to choose the right tool and how to score them.

The session will provide participants with education on the proper screening, diagnosis, and treatment of ADHD in children, adolescents, and adults.

7:00-7:30 a.m. Breakfast
7:30-9:00 a.m. Symposium

This educational activity is supported by an independent medical educational grant from Shire.
This activity is sponsored by CME LLC. Veritas Institute for Medical Education, Inc. is the content provider.

So you've got the basics of coding and documentation down. Now it's time for the real fun! Just when you thought picking the right code was easy! Here we go into depth regarding advanced of psychiatric and psychotherapy coding, with emphasis on advanced techniques such as the usage of modifiers, places of service other key components to coding correctly for maximizing reimbursement. We will also look at policies and procedures related to improving reimbursement such as benefit checking, service prepayment, payment variance audits and other areas in the revenue cycle. Included in the discussion will be case studies and examples.

Upon the completion of this activity, participants will be able to:

1. Understand and use advanced and rarely used CPT codes for services.
2. Understand what CPT Modifiers and Places of Service are and how to apply them.
3. Use policies and procedures to improve reimbursement and their relationship to proper coding and charging.

Psychiatrists are asked to render opinions and help in the management and treatment of a number of conditions which etiology may be primarily neurological, but its manifestations clearly psychiatric. Delirium is a transient, reversible organic mental syndrome caused by dysfunction in cerebral metabolism, characterized by an acute or subacute onset. Features of delirium include disturbance of consciousness, change in cognition, perceptual disturbances, global cognitive impairment, attentional abnormalities, increased or decreased psychomotor activity, and sleep-wake cycle disruption. Alcohol, medication intoxication, and withdrawal stages will be given special attention, as possible and common causes of delirium. The inappropriate treatment usually leads to improper treatment, thus delaying appropriate management.

Upon the completion of this activity, participants will be able to:

1. Understand the pathophysiology of delirium;
2. Understand the research-based, effective treatment options for delirium, including the use of atypical antipsychotic and other novel agents.
3. Learn research proven preventing techniques.

Iraq and Afghanistan veterans are returning home. Because so many are reservists, they will be coming back into civilian life.The prevalence of mental health disorders in these returning veterans is significant and very different in the clinical presentation than others with such conditions as PTSD. This seminar will address the identification of those veterans and their families in need, clinical interventions, and problems/solutions that therapists may face in providing services at all stages of the war experience, pre-deployment, deployment, and the return home.

By participating in this activity, participants will be able to:

1. Understand the importance of providing psychological, social, and/or psychiatric support for families of servicemen and service women in the different phases of War.
2. Appreciate the need for varied services (including addressing legal issues) to be delivered in different settings, including schools, work, places of worship, etc.
3. Gain further knowledge treating multiaxial aspects of the serviceman or service woman- and their families.

The session will encourage participants to explore the barriers of recognition and management of nonadherence in psychiatric patients with comorbid conditions and provide skills to balance long-term treatment requirements with optimized chronic care delivery.

This activty is supported by an educational grant from Eli Lilly and Company and Bristol-Myers Squibb and Otsuka America Pharmaceuticals, Inc.

This activity is sponsored by CME LLC.

Competent health care providers have to deal with many different aspects of their patients' lives - from social issues, financial issues, relationship issues, and cultural issues. Integrative therapies also address all of these areas. The application of Integrative therapies (which used to be known as "Complementary and Alternative Therapies") is now getting much more commonplace and is gaining in some areas of medicine greater acceptance. Your patients may be using herbs, meditation, massage, acupuncture, and aromatherapy because they believe that these integrative therapies may improve their health. As there are potential benefits and risks of these integrative therapies, whether they are being substituted for medications and/or psychotherapy or being used along with medications and/or psychotherapy, aspects of potential liability are also reviewed.

Upon the completion of this activity, participants will be able to:

1. Have knowledge of several Integrative Therapies your patients may be incorporating into their overall mental health care.
2. See how the paradigm of patient care may be shifting to include the use of Integrative Therapies and what some of the barriers are.
3. Understand how knowing- or not knowing- that your patient may be employing Integrative Therapies may have legal implications.

This course takes attendees on a provocative journey into the nature of happiness and the search for a novel framework for conceptualizing human nature - the human matrix. Practical ramifications for unstalling stalled treatment planning, enhancing the therapeutic alliance, preventing suicide, and creating a "tough resiliency" in both patients and clinicians are described in detail with clinical case examples.

By participating in this activity, attendees will be able to:

1. 1) Explain the concept of the human matrix model in everyday clinical practice, from engaging patients to treatment planning;
2. Discuss a unique definition of happiness and its implications for nurturing a resilient and "tougher happiness" and a more powerful style of treatment planning; and
3. Apply the principles of the "Human Matrix Model" for treatment planning, including healing matrix effects, damaging matrix effects, and the Red Herring Principle.

The best examination of a patient's neurocognitive status is a careful history and includes a clinical assessment that looks for variations from normal changes in a patient's neuroanatomy and records specific findings.

By participating in this activity, attendees will be able to:

List the primary domains of the neurocognitive mental status exam. 2) Employ simple, effective clinical tests to probe brain function. 3) Utilize systematic cognitive screening to confidently diagnose common dementia syndromes in geriatric patients.

The very common problem of partnered women who lose their desire for sexual behavior (HSDD) is addressed by understanding the nature of sexual desire, psychological intimacy, women's biology and the frequent transitions that occur within their lives. HSDD is an active arena of pharmacological research.

Upon the completion of this activity, participants will be able to:

1. Understand the individual, interpersonal, biological, and cultural aspects of sexual desire problems and their solutions.
2. Take a thorough history to estimate the patient's sexual desire situation.
3. Separate HSDD in women with ovarian function and those who are menopausal.
4. Appreciate the differences between a disorder model and a problem model.

The session will provide participants with strategies for improving rates of remission for major depressive disorder (MDD), including treatment resistant depression, along with combination and augmentation strategies for depression with atypical antipsychotics.

This activity is supported by an educational grant from Bristol-Myers Squibb and Otsuka America Pharmaceutical, Inc.

This activity is jointly sponsored by The Albert Einstein College of Medicine with Montefiore Medical Center and CME LLC. The Institute for Continuing Healthcare Education is the content provider.

Medication adherence can be a major challenge in patient care. This course will cover ten specific, practical and easily adopted interviewing techniques to improve medication adherence. These techniques are derived from the highly acclaimed motivational strategy known as the "medication interest model."

By participating in this activity, attendees will be able to:

1. Apply techniques such as the "inquiry into lost dreams" and the "trap-door question";
2. Identify the challenges in medication adherence by understanding how and why patients weigh the pros and cons of taking medications; and
3. Demonstrate the principles and applications of the medication interest model in a sophisticated fashion to a variety of difficult clinical situations.

This lecture synthesizes the concepts of love as a shifting nuanced series of nine ideas and vital interpersonal processes and skills. It emphasizes that temporary emotional disconnections are inevitable and elucidates the mechanisms that limit love's capacity to endure and flourish.

By participating in this activity, attendees will be able to:

1. Understand what love is and what it is not;
2. Recognize the universal aspects of connection-disconnection-reconnection as an inherent characteristic of long-term relationships;
3. Stimulate thoughts about the capacity of love relationships to generate symptoms that are often diagnosed and treated without reference to their likely origin; and
4. Provide a background for the other sexual topics in this lecture series.

Both psychiatric and nonpsychiatric clinicians tend to underutilize screeners and rating instruments in their busy practices. This is an error worth rectifying expeditiously for the following reasons: use of screeners and rating instruments can actually improve outcomes, it can be very time efficient and many quality tools are available for no charge. This workshop will show videos of a few clinical scenarios and discuss what tools might have been appropriate to use. Copies of noncopyrighted screeners and rating instruments, appropriate for both psychiatric and nonpsychiatric settings, will be made available to participants. A toolkit filled of screeners and rating instruments will be brought to the workshop to show participants how they can create one for their own use.

By participating in this activity, attendees will be able to:

1. Recognize the many noncopyrighted tools available for clinician use covering a range of psychiatric disorders;
2. Define these tools that are very time efficient and improve diagnostic yield; and
3. Describe how to choose the right tool and how to score them.

Upon completion of this activity, participants will be able to:

1. Detect and diagnose Alzheimer's disease (AD) using DSM-IV criteria, APA & AAN practice guidelines;
2. Utilize clinical information to differentiate AD from other cognitive disorders;
3. Optimally manage patients using both behavioral and pharmacological techniques.

This course provides an overview of a clinical approach to diagnosis, evaluation and management of autonomic disorders.

By participating in this activity, attendees will be able to:

1. Discuss the clinical cases of orthostatic hypotension, orthostatic intolerance, autonomic neuropathies and disorders of sweating;
2. Discuss patient care by highlighting the ways by which the clinician can provide useful consultations and effectively manage patients suffering from autonomic disorders; and
3. Formulate a differential diagnosis and offer a treatment plan for patients with common and less common varieties of autonomic dysfunction.

Headache is one of the most common of human afflictions. Nearly 30 million Americans live with migraine, but only a fraction of them receive effective treatment. The impact of inadequate or ineffective care is enormous, in both direct and indirect costs. The course discusses the update in the diagnosis and management of both primary and secondary headache disorders.

By participating in this activity, attendees will be able to:

1. Differentiate primary headache disorder from headache symptomatic of other disease;
2. Identify both episodic and chronic primary headache disorders; and
3. Discuss the treatment plans for both primary and secondary headache disorders.

Public outrage has justifiably ensued when convicted sex offenders who are released from prison commit subsequent sexual assaults.  At least seventeen states currently allow for the indeterminate civil commitment (i.e., locked psychiatric placement) of those sex offenders assessed as dangerous once they have completed their prison terms. These SVP statutes have engendered controversy both on constitutional and ethical grounds. All the DSM-IV-TR system can provide is a catalog of the specific mental disorders.  But which ones should count towards SVP civil commitment?

Upon the completion of this activity, participants will be able to:

1. Identify why twenty states have passed statutes mandating long term civil psychiatric commitment for sexually violent predators who are about to be released from prison.
2. List the legal and ethical difficulties that make this one of the most controversial areas in all of mental health practice.
3. Differentiate how well or poorly different DSM diagnoses fit into the statutory definition of mental disorder that triggers sexual predator civil commitment proceedings.

Is it better conceptualized as a state, a trait, or a culture-bound construct? Are there predictable and universal causes of human happiness? To what degree is one's degree of happiness modifiable by any life event or intervention? In this session, participants will get an introduction to the science of subjective well-being. The session will provide an overview of the history, epidemiology, social psychology and neurobiology of happiness.

By participating in this activity, attendees will be able to:

1. Identify the three psychological components of subjective well-being
2. Discuss the evidence that happiness is or is not related to wealth, health, love, or sexual activity; 3)Discuss the evidence of an inborn component to human happiness and;
3. List four interventions likely to lastingly enhance subjective well-being.

This is meditation's moment. From the cover of Time Magazine to the coffee table discussions of morning talk shows, meditation has acquired near mythic status both as an avenue to personal fulfillment and as a universal solvent against a dizzying array of diseases, mental and physical. However, despite increasing evidence that meditation may confer health benefits, significant gaps remain in our understanding of how meditation alters mind-body functioning to promote emotional and physical well-being. By providing a state-of-the-art update on what we do and do not know about meditation and meditation and mental health - with a focus on depression - this presentation will provide clinicians with information essential for thinking about how to incorporate meditation into their work with patients. The first talk in this program will provide an overview of research findings regarding mental health benefits of meditation, with a focus on rigorously examining areas of remaining uncertainty. The second talk will drill down deeper into a particular style of meditation - compassion meditation - to explore how this type of meditation may modulate deleterious stress responses relevant to health. The program will conclude with a chance for audience members to get a first hand sense of compassion meditation through a brief guided meditation.

At the end of this program, participants should be able to:

1. Describe the most important unanswered research questions regarding how to best apply meditation to mental illness.
2. Describe the different types of meditation practices that appear to offer the most promise as health interventions.
3. Describe how meditation practices may improve central nervous system, stress and immune functioning in ways likely to benefit mental and physical disease.
4. Describe what is known from the research literature regarding the effect of meditation on depression and anxiety in medically healthy and medically ill individuals.
5. Describe strategies for implementing meditation into clinical practice.

Upon the comletion of this activity, participants will be able to:

1. Define depression;
2. Outline causes and features of late life depression and discuss the known treatment modalities;
3. Assess therapy outcomes and how to improve these and;
4. Describe the need for maintenance therapy.

Upon the completion of this activity, participants will be able to:

1. Avoid major pitfalls of both tangible & intangible marketing;
2. Understand the ramifications of Customer Service & know how to offer patients "star treatment"; and
3. Develop a marketing budget and an effective 12-Month Marketing Plan, individualized for their practice.

In 1984, Libby Zion died of a fatal drug interaction, and her death led to our present system of residency workplace hourly restrictions. Despite these changes, would a well-rested clinician be able to recognize and prevent her death today?

By participating in this activity, attendees will be able to:

1. Recognize clinically relevant drug interactions;
2. Utilize a framework and teaching tool to predict those patients most at risk for serotonin syndrome and other drug interactions; and
3. Describe the cytochrome P450 system.

Pain is one of the most common reasons patients seek medical attention and a symptom encountered by every physician.  According to American Pain Society estimates, 50 million people are partially or totally disabled by pain and 45% of all Americans seek care for persistent pain at some point in their lives.  Neuropathic pain can be especially difficult to diagnose and treat. In this session, advances in the understanding of the causes of common neuropathic pain syndromes will be reviewed, and treatment options will be addressed.

As a result of participation, attendees will:

1. Be able to better recognize the onset of neuropathic pain.
2. Have a better understanding of a range of treatment options.
3. Will be better able to understand pain physiology and its ramifications.

This session will provide participants with an overview of human aggression. Based on the speaker's new chapter in the forthcoming Kaplan/Sadock Comprehensive Textbook of Psychiatry, this talk will summarize what we know about the origin, pathophysiology, and clinical management of aggression as it occurs in multiple disorders--from ADHD to organic brain injury. Sample cases will be used to illustrate optimum management based on state of the art literature review.

By participating in this activity, attendees will be able to:

1. Identify the brain regions most important for regulating individual human aggression;
2. Discuss how the evolutionary adaptation of sociality helps to explain war;
3. List the 7 big factors that help account for collective human aggression; and
4. Discuss the evidence that interventions to reduce intergroup prejudice can enhance the prospects of long-term peace.

This course will take an indepth look into the legal and ethical dilemmas in late life care. There will be a focus on the issues related to driving, inappropriate sexuality, financial issues, decision making and the right to refuse treatment.

Upon the completion of this activity, particpants will be able to:

1. Briefly describe the causes of dementia;
2. List the differences between normal aging and dementing illness;
3. Describe the stages of functional loss with age; and 4) List the general ethical concepts that govern the provision of care and apply these to a few common areas of concern

Join panelists Tracey Skale, MD, Tom Simpatico, MD, and Pete Earley , for a screening of a one-hour television program produced by The Fred Friendly Seminars for PBS: "MINDS ON THE EDGE: Facing Mental Illness" with a live interactive discussion to follow. The program connects dots between personal dilemmas facing individuals and families who are living with mental illness, medical practices that can be obstacles to treatment, and public policies that all too often fall short in providing support that could make a positive difference. Case studies will be examined across various barriers to treatment that occur both within and outside the provider domain. DVD Copies of MINDS ON THE EDGE will distributed to attendees at the session. Space is limited. More information on the program may be found at www.mindsonthedge.org.

At the end of this presentation, participants will be able to:

1. Discuss how the system of care for mental health, substance abuse and traumatic brain injury is currently fragmented, resulting in large numbers of afflicted persons becoming incarcerated in jails and prisons;
2. Discuss ways in which the current treatment technology for serious mental illness can more effectively be used to reach more people and prevent avoidable incarcerations and homelessness; and
3. Describe instances of barriers to treatment incurred by national, state, and municipal level legislation and the ethical dilemmas circulating these issues.

Upon the completion of this activity, participants will be able to:

1. Define the legal basis of the concept of negligence;
2. Enumerate the sources for the psychiatric standard of care; and
3. Determine which types of health information are protected by HIPAA.

The practice of psychiatry can be a source of both great satisfaction and great stress.

By participating in this activity, attendees will be able to:

1. Identify professional goals;
2. Recognize the steps for recovering from burnout and avoiding burnout altogether; and
3. Discuss the management of career-specific stressors, and how they can achieve balance between their personal and professional lives to maximize satisfaction.

Upon the completion of this activity, participants will be able to:

1. List Five Strategies to Modify Delivery of Medications;
2. Explain what are the possible pharmacodynamic advantages, which result from dosage formulation related changes in drug concentrations at their sites of action;
3. Identify future strategies for drug delivery and monitoring systems;
4. Summarize data available supporting (or not) the advantages of novel dosage forms;
5. Describe research strategies (and clinical approaches) to study the safety and efficacy of novel antipsychotic dosage forms.

This lecture will try to offer help in early detection, ways to conceptualize the disorder for families, and will emphasize the role of the practitioner to coordinate the many services and therapies needed. It will also emphasize how to talk about alternative therapies which may be questionable and how to treat comorbid symptoms. It should provide an approach to the patient who is early in diagnosis to help shape family attitudes toward constructive outcomes.

By participating in this session, attendee will be able to

1. List why there is a need for early autism interventions.
2. Recognize the necessity of initiating treatment immediately once a diagnosis of autism is suspected.
3. Recognize the early and unique signs of the autistic spectrum disorder in order to begin intervention.
4. Diagnose co-morbid problems which may respond to medication in autistic spectrum disorders.
5. Evaluate the role of a physician in directing parents and patients through the complexities of services required.

Dr. Weiner, a nationally regarded clinician and educator, has dedicated his career to helping health care professionals from medical students to chairmen of departments become happier people and better clinicians. This course, which will allow active audience participation, is based on years of working with stressed clinicians individually and in groups. At the end of this course, the audience will learn tools to successfully work on three things:

1. Identify the top causes of his or her professional stress.
2. Map out a personal plan to diminish or eliminate these stresses.
3. Create "SMART" goals and clear outcome measures to better align your career with what you value in life.

This lecture explores the phenomenon of limited male sexual interest and its relationship to the diagnosis of HSDD. It attempts to develop clinical sophistication and skepticism so that mental health professionals can efficiently decode patient presentations of low libido.

Participants should be able to:

1. To understand the separate roles of drive, motivation, and internalized cultural values in shaping sexual desire.
2. To realize that low sexual desire is quite clinically common in all psychiatric settings but HSDD is not.
3. To approach male sexual dysfunction with sophistication-desire and arousal problems are not always distinct-and skepticism-men lie about their sexual lives.

Though we all have a personality, a disorder exists only when personality traits have become so extreme, inflexible, and maladaptive that they markedly impair functioning and get the person in the same kind of trouble over and over again. It's Differentiation from normalcy will be discussed along with classification and corresponding treatment techniques, including: psychodynamic, cognitive, behavioral, interpersonal, and supportive.

Upon the completion of this activity, participants will be able to:

1. Describe the adaptive value of personality traits, how these survived via natural selection, and how to support them in helping patients cope with medical and psychiatric illness.
2. Distinguish personality disorders from Axis I conditions.
3. List several cognitive, behavioral, psychodynamic, supportive, and paradoxical approaches to the treatment personality disorders.

Part 1 of this 2-part course is titled "Five Secrets for Uncovering Hidden and Taboo Material." This informative and insightful talk discusses innovative techniques for increasing validity while exploring sensitive material such as suicidal ideation.

By participating in this activity, attendees will be able to:

1. Recognize the following five interviewing techniques for increasing validity: the behavioral incident, shame attenuation, gentle assumption, symptom amplification and denial of the specific;
2. Discuss the theory behind the use of these five techniques for uncovering valid information when exploring sensitive areas such as domestic violence, substance abuse histories and antisocial behavior; and
3. Describe and flexibly weave the above five validity techniques into effective methods of uncovering sensitive material while maintaining a powerful engagement.

Upon the compleion of this activiy, participants will be able to:

1. Describe the typical study design strategies used for the approval of a new antipsychotic in the United States and the European Union;
2. List the newly approved (and not approved) medications for the treatment of schizophrenia, and how they differ from current therapies;
3. Describe how the deconstruction of schizophrenia into endophenotypes and syndromes has stimulated a new generation of pharmacotherapeutic research and;
4. List novel possible drug therapies that appear to work via glutamate/glycinergic.

This talk explores the ongoing concerns about the increase in the popularity of a socially designated class of drugs known as "club drugs."

By participating in this activity, attendees will be able to:

1. Discuss the major categorization of club drugs and their pharmacological properties;
2. Identify the clinical and psychiatric manifestations of club drugs; and
3. Recognize available treatment approaches and harm reduction and prevention strategies.

This Lecture will outline the current thinking about Tourette syndrome since it often includes co-morbid ADHD, OCD, and Anxiety Disorders. The make up of this trinity will be discussed and the ramification of making this diagnosis, as well as impart on insurability, and the natural cause of the disorder. Medication use for symptoms in the context of the comorbid problems will be discussed.

By participating in this education activity, participants will be able to:

1. List the symptoms of Tourette's syndrome and differentiate the types of tics and movements which are often associated with this syndrome.
2. Recognize the potentiality for co-morbid diagnoses like ADHD and OCD.
3. Discuss the characteristics of a proper evaluation and also appreciate what not to do.
4. List resources to help patients and families once a diagnosis is made.
5. Understand the role of medications in treating the tics as well as the co-morbidities.

Upon the completion of this activity, participants will be able to:

1. Define the difference between forensic versus clinical evaluation.
2. Demonstrate knowledge of the concept of agency.
3. List the differences in approach between evaluating a clinical treatment patient and a forensic evaluee.

Part 2 of this 2-part course is titled "An Innovative Method for Eliciting Suicidal Ideation-the Chronological Assessment of Suicide Events." This informative and insightful talk discusses the practical application of the interview strategies for eliciting suicidal ideation and behavior in different psychiatric settings.

By participating in this activity, attendees will be able to:

1. Recognize the role of 4 specific interviewing techniques for improving the validity of elicited suicidal ideation while decreasing errors of omission and optimizing engagement;
2. Define the theory and practical application of a specific interview strategy for the elicitation of suicidal ideation and behaviors: the Chronological Assessment of Suicide Events (CASE approach); and
3. Discuss and flexibly utilize the above approach as a sensitive and rapid method of uncovering suicidal ideation and intent in a busy clinic or hospital setting.

Over the ages, our patients have at times been revered as saints, murdered as witches, and harmed with all manner of treatments that amounted to physical Abuse and/or poisoning. From the advent of humane psychiatry in the nineteenth century brought, the development of scientific psychiatry in the twentieth century, there has so far been surprisingly little transfer between the remarkably rich findings of neuroscience and the day to day clinical practice of psychiatry. We will discuss likely future trends and why a deep understanding of obsessive/compulsive disorder and bipolar disorder will probably long precede an understanding of major depression or schizophrenia.

1. Upon the comletion of this activity, participants will be able to:
   1. Describe how present day psychiatry emerged from myth and folk medicine and what the legacy of the past suggests about our future.
   2. Discuss he remarkable advances in neuroscience in the past 50 years and how these have, and have not, influenced the clinical practice of psychiatry.
   3. List likely ways in which psychiatric diagnosis and treatment will evolve in the coming decades.

Upon the completion of this activity, participants will be able to:

1. Describe the relative risk of comorbid substance abuse with other psychiatric syndromes.
2. Identify the available pharmacological agents for treatment of dual-diagnosis patients and medication treatment for substance dependence disorders.
3. Discuss the difficulties relating to the treatment and the harm reduction model vs. the abstinence model for dual-diagnosis patients.

Sexual excesses, particularly among men, have been known to exist since antiquity. The rise of the Internet and its exploding technologies have created frequent requests by wives and patients themselves for help with the loss of control over sexual behaviors. While not yet a DSM diagnostic category, the treatment of sexual addiction syndromes require a sophisticated clinical knowledge of sexual and general mental disorders.

Upon the completion of this activity, participants will be able to:

1. To be able to interact with patients without countertransference moral revulsion.
2. To be able to focus on the sexual excesses as the clinical problem rather than the associated psychopathology.
3. To understand the allure of pornography for normal individuals and for those with sexual excesses.

Does "Motion', that is, exercise have a place in our treatment armamentarium? This is a question all clinicians have frequently asked of themselves. The last decade of clinical and animal research has revealed surprising powerful positive effects of exercise on mood disorders. We now know that exercise affects brain volume, inflammatory cytokines, and the autonomic system. Clinical research data also points to exercise's powerful anti-depressant effects. In light of these exciting findings, this seminar is aimed at providing clinicians the research findings, as will as provide attendees with tools on how to "prescribe" exercise to their patients. Clinicians will be provided with tools to assist them in implementing an exercise prescribing program in their practices.

Upon the completion of the this activity, participants will be able to:

1. Develop an scientifically and data based appreciation of the complex neurobiology of exercise's positive effects on  on mood.
Examine the clinical, randomized data of exercise treatment in mood disorder and develop practical skills in applying this information to clinical care of patients.